Tokuji Ito
Osaka City University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tokuji Ito.
Journal of Hepato-biliary-pancreatic Sciences | 2014
Shoji Kubo; Masahiko Kinoshita; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Takayoshi Nishioka; Genya Hamano; Tokuji Ito; Makoto Abue; Masaru Aoki; Kei Nakagawa; Michiaki Unno; Susumu Hijioka; Toshihisa Fujiyoshi; Yasuhiro Shimizu; Toru Mizuguchi; Ken Shirabe; Akihiro Nishie; Yoshinao Oda; Kenji Takenaka; Tomonari Kobarai; Terumasa Hisano; Akio Saiura; Hiroshi Numao; Mayura Toda; Yuko Kuwae; Yasuni Nakanuma; Ginji Endo
Cholangiocarcinoma has been reported in workers exposed to chlorinated organic solvents and has consequently been classified as an occupational disease (occupational cholangiocarcinoma) by the Japanese Ministry of Health, Labour and Welfare. This study aimed to identify the characteristics of nine workers newly diagnosed with occupational cholangiocarcinoma.
World Journal of Gastroenterology | 2015
Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Takayoshi Nishioka; Akinori Nozawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Yorihisa Urata
Although liver resection is considered the most effective treatment for hepatocellular carcinoma (HCC), treatment outcomes are unsatisfactory because of the high rate of HCC recurrence. Since we reported hepatitis B e-antigen positivity and high serum hepatitis B virus (HBV) DNA concentrations are strong risk factors for HCC recurrence after curative resection of HBV-related HCC in the early 2000s, many investigators have demonstrated the effects of viral status on HCC recurrence and post-treatment outcomes. These findings suggest controlling viral status is important to prevent HCC recurrence and improve survival after curative treatment for HBV-related HCC. Antiviral therapy after curative treatment aims to improve prognosis by preventing HCC recurrence and maintaining liver function. Therapy with interferon and nucleos(t)ide analogs may be useful for preventing HCC recurrence and improving overall survival in patients who have undergone curative resection for HBV-related HCC. In addition, reactivation of viral replication can occur after liver resection for HBV-related HCC. Antiviral therapy can be recommended for patients to prevent HBV reactivation. Nevertheless, further studies are required to establish treatment guidelines for patients with HBV-related HCC.
European Surgical Research | 2015
Shogo Tanaka; Shigekazu Takemura; Hiroji Shinkawa; Takayoshi Nishioka; Genya Hamano; Masahiko Kinoshita; Tokuji Ito; Shoji Kubo
Background/Purpose: Laparoscopic hepatic resection (LH) for hepatocellular carcinoma (HCC) has gradually gained ground as a safe and minimally invasive treatment, although LH for cirrhotic patients remains challenging. Methods: Between January 2007 and August 2014, 28 and 57 patients with histologically proven cirrhosis (histological activity index, fibrosis score 4) underwent pure LH and open hepatic resection (OH; less than segmentectomy), respectively, for peripheral HCC ≤5 cm. To correct the difference in clinicopathological factors, including difficulty scores, between the two groups, propensity score matching was used at a 1:1 ratio, which resulted in a comparison of 20 patients per group. We compared the short- and long-term outcomes of LH and OH to investigate the efficacy of LH. Results: Clinicopathological variables, including difficulty scores, were well balanced between the two groups. The incidence of complications and mean intraoperative blood loss were lower in the LH group than the OH group (0 vs. 45% and 180 vs. 440 ml, p = 0.001 and 0.04, respectively). The 3-year disease-free survival rate was 42% in the LH group and 30% in the OH group (p = 0.533), whereas the 5-year overall survival rates were 46 and 60%, respectively (p = 0.606). Conclusions: LH is a safe and effective treatment option for cirrhotic patients with HCC in terms of intraoperative blood loss and morbidity.
Journal of Hepato-biliary-pancreatic Sciences | 2016
Masahiko Kinoshita; Shoji Kubo; Yasuni Nakanuma; Yasunori Sato; Shigekazu Takemura; Shogo Tanaka; Genya Hamano; Tokuji Ito; Hiroaki Terajima; Terumasa Yamada; Shoji Nakamori; Akira Arimoto; Masahiro Fujikawa; Yasuhiko Sugawara; Takatsugu Yamamoto; Makoto Abue; Kei Nakagawa; Michiaki Unno; Toru Mizuguchi; Kenji Takenaka; Ken Shirabe; Toshihiko Shibata
We aimed to identify the pathological characteristics of occupational cholangiocarcinoma.
Surgery Today | 2016
Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Takayoshi Nishioka; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Takatsugu Yamamoto; Makoto Abue; Masaru Aoki; Kei Nakagawa; Susumu Hijioka; Atsushi Miyamoto; Yukio Osaki; Ginji Endo; Shinji Kumagai
PurposeThis study aimed to establish an efficient strategy for screening and surveillance for occupational cholangiocarcinoma.MethodsWe evaluated the consecutive changes in laboratory findings during regular health examinations and in abdominal ultrasonography findings before the diagnosis of occupational cholangiocarcinoma in nine patients. The results of laboratory tests and abdominal ultrasonography at the time of diagnosis were also examined.ResultsIn all patients, the serum γ-glutamyl transpeptidase (γ-GTP) activity increased several years before the diagnosis of cholangiocarcinoma. The serum alanine aminotransferase (ALT) activity also increased several years before the diagnosis, following an increase in the serum aspartate aminotransferase (AST) activity in most patients. Abdominal ultrasonography before the diagnosis revealed regional dilatation of the bile ducts, which continued to enlarge. At the time of diagnosis, the γ-GTP, AST, and ALT activities were increased in nine, seven, and seven patients, respectively. The regional dilatation of bile ducts without tumor-induced stenosis, dilated bile ducts due to tumor-induced stenosis, space-occupying lesions, and/or lymph node swelling were observed. The serum concentrations of carbohydrate antigen 19-9 (CA 19-9) and/or carcinoembryonic antigen (CEA) were increased in all patients.ConclusionsRegular health examinations with a combination of ultrasonography and laboratory tests including the γ-GTP, AST, ALT, CA 19-9, and CEA levels are useful for screening and surveillance for occupational cholangiocarcinoma.
Journal of Surgical Oncology | 2016
Masahiko Kinoshita; Shoji Kubo; Shogo Tanaka; Shigekazu Takemura; Takayoshi Nishioka; Genya Hamano; Tokuji Ito; Sayaka Tanaka; Masahiko Ohsawa; Toshihiko Shibata
This study aimed to investigate the association between non‐alcoholic steatohepatitis (NASH) and intrahepatic cholangiocarcinoma (ICC).
Hepatology Research | 2016
Tokuji Ito; Shogo Tanaka; Shuji Iwai; Shigekazu Takemura; Atsushi Hagihara; Sawako Uchida-Kobayashi; Hiroji Shinkawa; Takayoshi Nishioka; Norifumi Kawada; Shoji Kubo
Percutaneous radiofrequency ablation (P‐RFA) therapy is a widely applied treatment for small hepatocellular carcinoma (HCC); however, local recurrence is a major issue of HCC located at the surface of the liver (surface HCC). The aim of this study was to compare the outcome of laparoscopic hepatic resection (LH) and P‐RFA for surface HCC in case–control patient groups using the propensity score.
Journal of Hepato-biliary-pancreatic Sciences | 2016
Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Masaki Koda; Takanori Aota; Takatsugu Yamamoto; Hiroaki Terajima; Gorou Tachiyama; Terumasa Yamada; Shoji Nakamori; Akira Arimoto; Masahiro Fujikawa; Yoshito Tomimaru; Yasuhiko Sugawara; Kei Nakagawa; Michiaki Unno; Toru Mizuguchi; Kenji Takenaka; Koichi Kimura; Ken Shirabe; Akio Saiura; Katsuhiko Uesaka; Hiroki Taniguchi; Akira Fukuda; Ja-Mun Chong; Yuko Kuwae
Cholangiocarcinoma caused by exposure to 1,2‐dichloropropane and/or dichloromethane is recognized as occupational cholangiocarcinoma. The aim of this study was to investigate the outcomes after resection of occupational cholangiocarcinoma to establish a treatment strategy for this disease.
Journal of Hepato-biliary-pancreatic Sciences | 2016
Genya Hamano; Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Masahiko Kinoshita; Tokuji Ito; Takatsugu Yamamoto; Kenichi Wakasa; Toshihiko Shibata
An outbreak of cholangiocarcinoma has been reported among workers of an offset color proof‐printing department at a printing company in Japan. In this study, we compared the clinicopathological findings of this type of intrahepatic cholangiocarcinoma (occupational ICC) and non‐occupational ICC.
Liver cancer | 2018
Masaki Koda; Shogo Tanaka; Shigekazu Takemura; Hiroji Shinkawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Norifumi Kawada; Toshihiko Shibata; Shoji Kubo
Background: Although studies have reported on long-term (10-year) survival after hepatic resection for hepatocellular carcinoma (HCC), they did not focus on patients with hepatitis C virus (HCV)-related HCC, and the contribution of antiviral therapy to long-term survival (especially ≥15 years) has not been adequately examined. We investigated the long-term outcome after hepatic resection for HCV-related HCC, including the effects of interferon (IFN) therapy, and the changes in prognostic factors according to postoperative duration. Methods: The data of 207 patients who underwent hepatic resection for HCV-related HCC between January 1992 and December 2001 were retrospectively reviewed. We investigated the disease-free and overall survival rates after surgery and analyzed the prognostic factors at 5, 10, and 15 years postoperatively. Results: The proportion of patients who survived at 5, 10, and 15 years after hepatic resection was 52% (n = 107), 18% (n = 38), and 9% (n = 19). The overall survival rate was significantly higher in patients who achieved sustained virological response (SVR) with IFN therapy than in those without SVR. Tumor-related factors such as multiple tumor, microscopic vascular invasion, and a high indocyanine green retention rate at 15 min (ICGR15) were unfavorable prognostic factors for 5-year survival. Conversely, a low ICGR15 and SVR were favorable prognostic factors at 10 years, and SVR alone was a favorable prognostic factor at 15 years postoperatively; no tumor-related factors were prognostic factors at 10 and 15 years postoperatively. Conclusion: The prognostic factors varied according to the duration after hepatic resection for HCV-related HCC. Tumor-related factors were unfavorable prognostic factors in the early postoperative period, whereas SVR and good liver function were favorable prognostic factors at 10 and 15 years postoperatively. Achievement of SVR with IFN therapy is essential for long-term (≥15 years) survival after hepatic resection for HCV-related HCC.